Search
VB10.16
go.drugbank.com/drugs/DB17512InvestigationalIt is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, and the part encoding a protein that specifically binds to antigen-presenting … VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers.
PN0621
go.drugbank.com/drugs/DB05218ExperimentalIt targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis. It is being developed by Peptech.
Foretinib
go.drugbank.com/drugs/DB12307InvestigationalForetinib is an orally available small molecule compound designed to target multiple RTKs implicated in the development, progression and spread of cancer. … It inhibits the activation of MET, RON, ERK and AKT, decreased proliferation and increased apoptosis.
N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid
go.drugbank.com/drugs/DB03458ExperimentalThis compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.
MX6
go.drugbank.com/drugs/DB05789ExperimentalMX6 is adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. … used to treat or prevent cervical cancers and precancers such as cervical dysplasias, including high grade and low grade dysplasias.
Fluoride ion
go.drugbank.com/drugs/DB11257ApprovedInvestigationalIt also plays an essential physiological role, such as enhancing the resistance profile and strength of the surface tooth enamel. … Having a chemical formula of F−, fluoride ion is the simplest inorganic, monatomic anion of fluorine with basic properties. It is considered a trace element.
Cortisone
go.drugbank.com/drugs/DB14681InvestigationalIt is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)
Categories: Corticosteroid Hormone Receptor AgonistsSynonyms: Kendall's compound EATX-201
go.drugbank.com/drugs/DB05765InvestigationalIt is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX-201 clinical program for actinic keratosis. … The Company determined that the program was not meeting their expected primary and exploratory objectives.
MM-093
go.drugbank.com/drugs/DB05512InvestigationalResearch on AFP suggests that it may play a role in modulating the immune system of the mother in order to protect the developing fetus during pregnancy. … Current studies are assessing MM-093’s potential to improve the treatment of autoimmune disease.
TG-100801
go.drugbank.com/drugs/DB05075InvestigationalIt is administered noninvasively as an eye drop and is designed to suppress VEGF mediated leakage and additional kinase targets associated with inflammation, edema, and angiogenesis which are the pathological … hallmarks of AMD and other back of the eye diseases including diabetic macular edema and proliferative diabetic retinopathy.